[
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/9ptbe/", 
        "description": "To determine whether scatter argon laser photocoagulation can prevent the development of neovascularization.\n \n \n        To determine whether peripheral scatter argon laser photocoagulation can prevent vitreous hemorrhage.\n \n \n        To determine whether macular argon laser photocoagulation can improve visual acuity in eyes with macular edema reducing vision to 20/40 or worse.", 
        "title": null, 
        "phase": "Phase 3", 
        "nct_id": "NCT00000162", 
        "condition": [
            "Macular Degeneration", 
            "Neovascularization, Pathologic", 
            "Vitreous Hemorrhage"
        ], 
        "initial_release_date": "1999-09-23"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/t7gd6/", 
        "description": "To determine whether postoperative subconjunctival injections of 5-fluorouracil (5-FU) increase the success rate of filtering surgery in patients at high risk for failure after standard glaucoma filtering surgery.", 
        "title": null, 
        "phase": "Phase 3", 
        "nct_id": "NCT00000122", 
        "condition": "Glaucoma", 
        "initial_release_date": "1999-09-23"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/siec6/", 
        "description": "To determine whether photocoagulation helps prevent severe visual loss from proliferative diabetic retinopathy.\n \n \n        To determine whether a difference exists in the efficacy and safety of argon versus xenon photocoagulation for proliferative diabetic retinopathy.", 
        "title": null, 
        "phase": "Phase 3", 
        "nct_id": "NCT00000160", 
        "condition": [
            "Diabetic Retinopathy", 
            "Blindness"
        ], 
        "initial_release_date": "1999-09-23"
    }, 
    {
        "status": "Withdrawn", 
        "osf_url": "localhost:5000/encsx/", 
        "description": "The purpose of this study is to evaluate the effects of gamma hydroxybutyric on naloxone-precipitated opiate withdrawal.", 
        "title": "Neurobiology of Opioid Dependence: 2", 
        "phase": "Phase 2", 
        "nct_id": "NCT00000193", 
        "condition": "Opioid-Related Disorders", 
        "initial_release_date": "1999-09-20"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/8atwg/", 
        "description": "The purpose of this study is to conduct human laboratory studies of possible cocaine interactions with various potential treatment medications.", 
        "title": "Pharmacological Modulation of Cocaine Effects", 
        "phase": "Phase 2", 
        "nct_id": "NCT00000201", 
        "condition": "Cocaine-Related Disorders", 
        "initial_release_date": "1999-09-20"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/j7s9q/", 
        "description": "Randomized study.  All patients must be randomized to treatment on Arms I and II within 3 months of definitive surgery on Regimen A.\n \n \n        Regimen A:  Surgery followed, as indicated, by Radiotherapy.  Amputation; or limb-sparing resection followed by involved-field irradiation using megavoltage equipment with or without electron boost.\n \n \n        Arm I:  2-Drug Combination Chemotherapy with Hematologic Toxicity Attenuation and Urothelial Protection.  Doxorubicin, DOX, NSC-123127; Ifosfamide, IFF, NSC-109724; with Granulocyte Colony Stimulating Factor (Amgen), G-CSF,\n \n \n        NSC-614629; and Mesna, NSC-113891.\n \n \n        Arm II:  Observation.  No adjuvant chemotherapy.", 
        "title": "A Randomized Study of the Effect of Adjuvant Chemotherapy With Doxorubicin and Ifosfamide With Mesna in the Treatment of High-Grade Adult Extremity Soft Tissue Sarcoma", 
        "phase": "Phase 3", 
        "nct_id": "NCT00001300", 
        "condition": "Sarcoma", 
        "initial_release_date": "1999-11-03"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/gwi3m/", 
        "description": "RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.\n \n  PURPOSE: Phase II trial to study the effectiveness of combining irinotecan and docetaxel in treating patients who have recurrent or metastatic non-small cell lung cancer.", 
        "title": "A Phase II Study of Irinotecan (CPT-11) and Docetaxel (Taxotere) in Patients With Recurrent Non-Small Cell Lung Cancer", 
        "phase": "Phase 2", 
        "nct_id": "NCT00003900", 
        "condition": "Lung Cancer", 
        "initial_release_date": "1999-11-01"
    }, 
    {
        "status": "Terminated", 
        "osf_url": "localhost:5000/dhmba/", 
        "description": "OBJECTIVES:\n \n  Evaluate the safety and efficacy of lucinactant administered by bronchoalveolar lavage (BAL) in the treatment of meconium aspiration syndrome (MAS) in newborn infants.", 
        "title": "A Multicenter, Randomized, Controlled Trial Comparing the Safety and Effectiveness of Bronchoalveolar Lavage With Lucinactant to Standard Care for the Treatment of the Meconium Aspriation Syndrome (MAS) in Newborn Infants", 
        "phase": "Phase 3", 
        "nct_id": "NCT00004500", 
        "condition": "Meconium Aspiration", 
        "initial_release_date": "1999-10-18"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/zd5x4/", 
        "description": "The purpose of this study is to determine whether different types of antidepressant medicines relieve back pain that has lasted at least six months on a daily basis.  Study participants will be assigned to treatment with either a antidepressant acting on the serotonin system in the brain (fluoxetine), one acting on the noradrenaline system (desipramine, or to a control medication not expected to relieve pain (benztropine).  Each participant will be seen at least nine times during their 12 weeks on medication.  This is a phase 2/3, outpatient study.", 
        "title": "Efficacy of Antidepressants in Chronic Back Pain", 
        "phase": "Phase 2", 
        "nct_id": "NCT00018200", 
        "condition": [
            "Back Pain", 
            "Sciatica"
        ], 
        "initial_release_date": "2001-07-03"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/dc9es/", 
        "description": "RATIONALE: Drugs used in chemotherapy, such as topotecan and cyclophosphamide, use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with autologous stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells.\n \n  PURPOSE: This phase I trial is studying the side effects of induction chemotherapy using cyclophosphamide and topotecan in treating patients who are undergoing surgery and autologous stem cell transplantation followed by radiation therapy for newly diagnosed or progressive neuroblastoma.", 
        "title": "A Pilot Induction Regimen Incorporating Topotecan for Treatment of Newly Diagnosed High Risk Neuroblastoma", 
        "phase": "Phase 1", 
        "nct_id": "NCT00070200", 
        "condition": "Neuroblastoma", 
        "initial_release_date": "2003-10-03"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/mtswb/", 
        "description": "RATIONALE: PKC412 may stop the growth of cancer cells by blocking the enzymes necessary for their growth. It may also increase the effectiveness of daunorubicin and cytarabine by making cancer cells more sensitive to the drugs. Drugs used in chemotherapy, such as daunorubicin and cytarabine, work in different ways to stop cancer cells from dividing so they stop growing or die. Combining PKC412 with chemotherapy may kill more cancer cells.\n \n  PURPOSE: This phase I trial is studying the side effects and best way to give PKC412 when given either after or together with daunorubicin and cytarabine in treating patients with newly diagnosed acute myeloid leukemia.", 
        "title": "A Phase IB, Open-Label Study to Determine the Safety and Pharmacokinetics of Twice Daily Oral Dosing of PKC412 Administered in Combinations Sequentially and Concomitantly With Daunorubicin and Cytarabine for Standard Induction Therapy, and High Dose Cytarabine for Consolidation in Patients With Acute Myeloid Leukemia (AML)", 
        "phase": "Phase 1", 
        "nct_id": "NCT00093600", 
        "condition": "Acute Myeloid Leukemia (AML)", 
        "initial_release_date": "2004-10-06"
    }, 
    {
        "status": "Completed", 
        "osf_url": "localhost:5000/xjfa8/", 
        "description": "This Phase 3, open-label, multicenter study is designed to compare the effects of exenatide and insulin glargine (Lantus\u00ae injection) on beta-cell function in patients with type 2 diabetes mellitus using metformin.", 
        "title": "A Phase 3, Randomized, Open Label, Comparator-Controlled, Parallel Group, Multicenter Study to Compare the Effects of Exenatide and Insulin Glargine on Beta Cell Function and Cardiovascular Risk Markers in Subjects With Type 2 Diabetes Treated With Metformin Who Have Not Achieved Target HbA1c", 
        "phase": "Phase 3", 
        "nct_id": "NCT00097500", 
        "condition": "Type 2 Diabetes Mellitus", 
        "initial_release_date": "2004-11-24"
    }
]